David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Avery Dennison
AVY
$13.8B
| $1.21M | ﹤0.01% |
+9,218
| New | +$1.16M |
|
2802
Methode Electronics
MEI
$606M
| $1.21M | ﹤0.01% |
30,617
-15,325
| -33% | -$556K |
|
2803
PUT
Resideo Technologies
REZI
$3.02B
| $1.2M | ﹤0.01% |
100,700
+50,000
| +99% | +$569K |
|
2804
CALL
Cencora
COR
$62.6B
| $1.2M | ﹤0.01% |
14,100
| – | – |
|
2805
Boston Beer
SAM
$1.91B
| $1.2M | ﹤0.01% |
3,167
-20,287
| -86% | -$7.64M |
|
2806
Cogent Communications
CCOI
$515M
| $1.2M | ﹤0.01% |
18,172
+4,891
| +37% | +$295K |
|
2807
Scorpio Tankers
STNG
$3.75B
| $1.2M | ﹤0.01% |
+30,412
| New | +$1.04M |
|
|
SBBP
2808
DELISTED
Strongbridge Biopharma plc.
SBBP
| $1.2M | ﹤0.01% |
572,225
-327,008
| -36% | -$627K |
|
|
I
2809
CALL
DELISTED
INTELSAT S. A.
I
| $1.2M | ﹤0.01% |
+170,000
| New | +$2.67M |
|
2810
CALL
Enbridge
ENB
$110B
| $1.19M | ﹤0.01% |
+30,000
| New | +$1.12M |
|
|
GBT
2811
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.19M | ﹤0.01% |
15,000
| – | – |
|
2812
PUT
Everest Group
EG
$14.6B
| $1.19M | ﹤0.01% |
4,300
+3,200
| +291% | +$844K |
|
|
LM
2813
DELISTED
Legg Mason, Inc.
LM
| $1.19M | ﹤0.01% |
33,118
+27,756
| +518% | +$1.03M |
|
|
AYX
2814
DELISTED
Alteryx Inc
AYX
| $1.19M | ﹤0.01% |
11,860
-171,855
| -94% | -$17.5M |
|
2815
AGNC Investment
AGNC
$12.8B
| $1.19M | ﹤0.01% |
+67,076
| New | +$1.14M |
|
2816
Liberty Latin America Class C
LILAK
$1.68B
| $1.19M | ﹤0.01% |
71,199
-31,163
| -30% | -$482K |
|
|
WIFI
2817
DELISTED
Boingo Wireless, Inc.
WIFI
| $1.18M | ﹤0.01% |
+108,090
| New | +$1.17M |
|
2818
Ingevity
NGVT
$2.39B
| $1.18M | ﹤0.01% |
13,530
+1,333
| +11% | +$117K |
|
|
WDR
2819
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $1.18M | ﹤0.01% |
70,672
+2,556
| +4% | +$41.7K |
|
|
FOCS
2820
PUT
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $1.18M | ﹤0.01% |
40,000
-100,000
| -71% | -$2.56M |
|
2821
PUT
Jack in the Box
JACK
$316M
| $1.18M | ﹤0.01% |
+15,100
| New | +$1.25M |
|
2822
United Microelectronic
UMC
$47.7B
| $1.18M | ﹤0.01% |
439,640
-6,276
| -1% | -$15.2K |
|
2823
Solid Biosciences
SLDB
$1.04B
| $1.18M | ﹤0.01% |
17,634
+12,466
| +241% | +$1.38M |
|
2824
PUT
Under Armour
UAA
$2.21B
| $1.18M | ﹤0.01% |
54,400
-100
| -0.2% | -$1.94K |
|
2825
FerroAtlántica
GSM
$761M
| $1.17M | ﹤0.01% |
1,248,457
-6,478
| -0.5% | -$4.82K |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.